Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.94 USD
−50.39 M USD
353.00 K USD
81.96 M
About aTyr Pharma, Inc.
Sector
CEO
Sanjay S. Shukla
Headquarters
San Diego
Website
Founded
2005
FIGI
BBG001J2P692
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ATYR is 3.17 USD — it has decreased by −3.65% in the past 24 hours. Watch aTyr Pharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange aTyr Pharma, Inc. stocks are traded under the ticker ATYR.
ATYR stock has fallen by −5.37% compared to the previous week, the month change is a 0.63% rise, over the last year aTyr Pharma, Inc. has showed a 173.28% increase.
We've gathered analysts' opinions on aTyr Pharma, Inc. future price: according to them, ATYR price has a max estimate of 35.00 USD and a min estimate of 9.00 USD. Watch ATYR chart and read a more detailed aTyr Pharma, Inc. stock forecast: see what analysts think of aTyr Pharma, Inc. and suggest that you do with its stocks.
ATYR reached its all-time high on Jun 4, 2015 with the price of 5,544.84 USD, and its all-time low was 1.08 USD and was reached on Nov 13, 2023. View more price dynamics on ATYR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ATYR stock is 5.79% volatile and has beta coefficient of 1.11. Track aTyr Pharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is aTyr Pharma, Inc. there?
Today aTyr Pharma, Inc. has the market capitalization of 266.10 M, it has increased by 6.01% over the last week.
Yes, you can track aTyr Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
aTyr Pharma, Inc. is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ATYR earnings for the last quarter are −0.23 USD per share, whereas the estimation was −0.22 USD resulting in a −4.55% surprise. The estimated earnings for the next quarter are −0.23 USD per share. See more details about aTyr Pharma, Inc. earnings.
aTyr Pharma, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 21.67 K USD. In the next quarter, revenue is expected to reach 20.00 K USD.
ATYR net income for the last quarter is −17.26 M USD, while the quarter before that showed −16.31 M USD of net income which accounts for −5.84% change. Track more aTyr Pharma, Inc. financial stats to get the full picture.
No, ATYR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 12, 2024, the company has 59.00 employees. See our rating of the largest employees — is aTyr Pharma, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. aTyr Pharma, Inc. EBITDA is −66.11 M USD, and current EBITDA margin is −14.78 K%. See more stats in aTyr Pharma, Inc. financial statements.
Like other stocks, ATYR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade aTyr Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So aTyr Pharma, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating aTyr Pharma, Inc. stock shows the neutral signal. See more of aTyr Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.